RT Journal Article
SR Electronic
T1 Persistence of SARS-CoV-2 omicron variant in children and utility of rapid antigen testing as an indicator of culturable virus
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.06.21.22276668
DO 10.1101/2022.06.21.22276668
A1 Zoe M. Lohse
A1 Jerne J. Shapiro
A1 John A. Lednicky
A1 Melanie N. Cash
A1 Inyoung Jun
A1 Carla N. Mavian
A1 Massimiliano S. Tagliamonte
A1 Cyrus Saleem
A1 Yang Yang
A1 Eric J. Nelson
A1 Marco Salemi
A1 Kathleen A. Ryan
A1 J. Glenn Morris, Jr.
YR 2022
UL http://medrxiv.org/content/early/2022/06/22/2022.06.21.22276668.abstract
AB We screened 65 longitudinally-collected nasal swab samples from 31 children aged 0-16 years who were positive for SARS-CoV-2 omicron BA.1. By day 7 after onset of symptoms 48% of children remained positive by rapid antigen test. In a sample subset we found 100% correlation between antigen test results and virus culture.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded through internal funding mechanisms at the University of FloridaAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of University of Florida gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors, contingent upon compliance with requirements of the University of Florida IRB